Recherche
Enseignement
Solutions
S'identifier
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Medical Chemistry,
Faculty of Medicine,
Doctoral School of Molecular Medicine,
Department of Medical Chemistry, Faculty of Medicine
Eliza Guti has not added Biography.
If you are Eliza Guti and would like to personalize this page please email our Author Liaison for assistance.
The multitargeted receptor tyrosine kinase inhibitor sunitinib induces resistance of HER2 positive breast cancer cells to trastuzumab-mediated ADCC.
Cancer immunology, immunotherapy : CII Sep, 2022 | Pubmed ID: 35066605
University of Debrecen
Eliza Guti*,1,2,
Ákos Máté Bede*,1,3,
Csongor Váróczy*,1,3,
Csaba Hegedűs1,
Máté Á. Demény1,4,
László Virág1,4
1Department of Medical Chemistry, Faculty of Medicine, University of Debrecen,
2Doctoral School of Molecular Medicine, University of Debrecen,
3National Academy of Scientist Education, University of Debrecen,
4, ELKH-DE Cell Biology and Signaling Research Group
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
Copyright © 2024 MyJoVE Corporation. Tous droits réservés.